海特生物：公司药品生产许可证变更

Core Viewpoint - Hite Bio (300683.SZ) has recently obtained a renewed drug production license from the Hubei Provincial Drug Administration, allowing for changes in the entrusted or contracted production of drugs [1] Group 1 - The company has added a new entrusted product: injectable Nemonoxacin mesylate, which is limited to registration and declaration use [1] - The contracting party for the new product is Fujian Dapu Biopharmaceutical Co., Ltd. [1]